NDC 80425-0033-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0033
- Requested NDC
- 80425-0033-01
- Package NDCs from labels
- 80425-0033-4, 80425-0033-1, 80425-0033-2, 80425-0033-3, 80425-0033-5, 80425-0033-6, 80425-0033-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2026-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0033-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 12 | |
| 80425-0033-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 12 | |
| 80425-0033-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 12 | |
| 80425-0033-4 | Gabapentin | 40 in 1 BOTTLE | CAPSULE | 40 | 12 | |
| 80425-0033-5 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 12 | |
| 80425-0033-6 | Gabapentin | 9 in 1 BOTTLE | CAPSULE | 9 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0033 | GABAPENTIN CAPSULE [ADVANCED RX OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250221_afc83432-8fce-6d2a-e053-2a95a90ae73f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0033-1 | EA - Each | 80425-0033 | 9436a3ad-de85-4153-a6c1-1bc48a0c0ea9 | 1 | 2023-06-06 |
| 80425-0033-2 | EA - Each | 80425-0033 | f1d09a02-72a4-486f-a426-6c8d6d9fd956 | 1 | 2023-06-06 |
| 80425-0033-3 | EA - Each | 80425-0033 | 98f4b8be-49fb-4eaa-b05b-544343fd0e05 | 1 | 2023-06-06 |
| 80425-0033-4 | EA - Each | 80425-0033 | a3084993-3234-4a78-b106-1d887c7721c4 | 1 | 2023-06-06 |
| 80425-0033-5 | EA - Each | 80425-0033 | 869fe2d3-45a1-4521-b1b8-9b0a28976912 | 1 | 2025-03-04 |
| 80425-0033-6 | EA - Each | 80425-0033 | 2cb2f884-e0fb-4a65-b21b-67d983685b75 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Trifluent Pharma, LLC | 59442de1-7cf0-35f6-e063-6294a90a57d7 | 2026-08-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | cb81fd89-b32b-4538-bf5c-ab02f65b3458 | 2026-08-07 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 691205ba-fa65-4bc9-ba20-7d361382cff9 | 2026-08-07 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 97e47698-97c9-4eb5-a108-5850c2aa2818 | 2026-08-07 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 2ac0622c-440a-49a0-974f-726e6ac72a0e | 2026-08-07 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 48037fc4-1aab-4ae8-aede-7c55b494877a | 2026-08-07 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | ddb3a54f-5224-4024-8804-b2a2f01d885e | 2026-08-06 | Warnings, Adverse reactions | ANDA090858 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fce0c123-29d7-42bf-8c8d-8be1772e2d99 | 2026-08-06 | Warnings, Adverse reactions | ANDA090858 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 583ab038-7b6e-96f8-e063-6294a90adf47 | 2026-08-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | TIME CAP LABORATORIES, INC | 08880902-bd44-41b6-866b-2cbad4c3f2b1 | 2026-07-30 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 81243958-cc5a-4ec0-a64d-71682f949d5f | 2026-07-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | bc525ae4-9843-4038-a1b7-0d3543e2282c | 2026-07-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 41844c21-9e2a-4332-a8ff-9b71ae9032b0 | 2026-07-30 | Warnings, Adverse reactions | ANDA090858 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | TAGI Pharma, Inc. | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 2026-07-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 722de2a9-38b3-4518-b262-ba0d1346d0ba | 2026-07-24 | Warnings, Adverse reactions | ANDA090858 67877-223 310430 310432 310431 f1432ab9-9c63-4880-8c9b-b851c16dc765 722de2a9-38b3-4518-b262-ba0d1346d0ba 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 5a78ab50-993d-4857-be10-be665e02b353 | 2026-07-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 57383d2a-d2c7-bbdc-e063-6294a90ada98 | 2026-07-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 16542ee6-0e0e-4d3c-8b32-60ff6ef48846 | 2026-07-21 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 32169228-e85c-4dbf-8722-cd2f8e0f5d1a | 2026-07-20 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 4a95f18e-0de4-4ce1-9f97-bc2e8a5bac6a | 2026-07-17 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.